Inventor · disambiguated record
Agnete Brunsvik Fredriksen
Also filed as: FREDRIKSEN AGNETE · FREDRIKSEN AGNETE B · FREDRIKSEN AGNETE BRUNSVIK
9 granted patents·15 pending applications·14 citations·filing 2011–2024
82Inventor score
Top patents by PatentIndex Score
24 records- 0183US10590195B2Homodimeric protein constructsRUFFINI PIER ADELCHI·Filed 2011·Granted Mar 17, 2020·8 cites·13 claims
- 0281US9169322B2Modified antibodyBOGEN BJARNE·Filed 2012·Granted Oct 27, 2015·3 cites·29 claims
- 0381US2023303718A1Modified AntibodyNykode Therapeutics ASA·Filed 2023·Application pending·0 cites
- 0476US11780924B2HLA binding vaccine moieties and uses thereofUNIV OSLO·Filed 2017·Granted Oct 10, 2023·1 cites·12 claims
- 0575US12059459B2Therapeutic anticancer neoepitope vaccineNykode Therapeutics ASA·Filed 2021·Granted Aug 13, 2024·1 cites·22 claims
- 0673US12358989B2HLA binding vaccine moieties and uses thereofUNIV OSLO·Filed 2023·Granted Jul 15, 2025·0 cites·14 claims
- 0764US2024350601A1Therapeutic Anticancer Neoepitope VaccineNykode Therapeutics ASA·Filed 2024·Application pending·0 cites
- 0862US2018030155A1Modified AntibodyVACCIBODY AS·Filed 2017·Application pending·0 cites
- 0961US11479605B2Homodimeric protein constructsNykode Therapeutics ASA·Filed 2020·Granted Oct 25, 2022·0 cites·19 claims
- 1060US2022111023A1Neoepitope rna cancer vaccineVACCIBODY AS·Filed 2021·Application pending·0 cites
- 1158US9901635B2Vaccines against HPVVACCIBODY AS·Filed 2012·Granted Feb 27, 2018·1 cites·22 claims
- 1257US9796787B2Modified antibodyVACCIBODY AS·Filed 2015·Granted Oct 24, 2017·0 cites·20 claims
- 1357US2025049910A1Immunogenic Constructs And Vaccines For Use In The Prophylactic And Therapeutic Treatment Of Diseases Caused By SARS-CoV-2Nykode Therapeutics ASA·Filed 2022·Application pending·0 cites
- 1452US2025195632A1Tolerance-inducing constructs and composition and their use for the treatment of immune disordersNykode Therapeutics ASA·Filed 2022·Application pending·0 cites
- 1551US2025222085A1Co-expression of constructs and immunostimulatory compoundsNykode Therapeutics ASA·Filed 2022·Application pending·0 cites
- 1651US2024252625A1Co-expression of constructs and immunoinhibitory compoundsNykode Therapeutics ASA·Filed 2022·Application pending·0 cites
- 1749US2025288654A1Tolerance-inducing constructs and compositions and their use for the treatment of immune disordersNykode Therapeutics ASA·Filed 2022·Application pending·0 cites
- 1849US2025339509A1Immunogenic constructs and vaccines for use in the prophylactic and therapeutic treatment of infectious diseasesNykode Therapeutics ASA·Filed 2022·Application pending·0 cites
- 1944US2019022202A1Therapeutic anticancer neoepitope vaccineVACCIBODY AS·Filed 2017·Application pending·0 cites
- 2042US12462898B2Method for selecting neoepitopesNykode Therapeutics ASA·Filed 2019·Granted Nov 4, 2025·0 cites·20 claims
- 2142US2023165952A1Betacoronavirus prophylaxis and therapyNykode Therapeutics ASA·Filed 2021·Application pending·0 cites
- 2242US2023293650A1Individualized therapeutic anticancer vaccineNykode Therapeutics ASA·Filed 2021·Application pending·0 cites
- 2339US2019015491A1Neoepitope rna cancer vaccineVACCIBODY AS·Filed 2017·Application pending·0 cites
- 2437US2016031991A1Targeting vaccines for veterinary useVACCIBODY AS·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Agnete Brunsvik Fredriksen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →